Log In
BCIQ
Print this Print this
 

Alinia, nitazoxanide

  Manage Alerts
Collapse Summary General Information
Company Romark Laboratories L.C.
DescriptionNitrothiazolyl-salicylamide compound
Molecular Target Pyruvate ferredoxin oxidoreductase
Mechanism of ActionPyruvate ferredoxin oxidoreductase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/23/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today